The BARD1/HP1 interaction: Another clue to heterochromatin involvement in homologous recombination

por Fukuda, Takayo, Tsuruga, Tomoko, Kuroda, Takako, Takeuchi, Jun, Wu, Wenwen, Ohta, Tomohiko
Publicado 2015

Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, a...

por Fukuda, Takayo, Tanabe, Masahiko, Kobayashi, Kokoro, Fukada, Ippei, Takahashi, Shunji, Iwase, Takuji, Ito, Yoshinori
Publicado 2015

MED12 exon 2 mutations in phyllodes tumors of the breast

por Nagasawa, Satoi, Maeda, Ichiro, Fukuda, Takayo, Wu, Wenwen, Hayami, Ryosuke, Kojima, Yasuyuki, Tsugawa, Ko-ichiro, Ohta, Tomohiko
Publicado 2015

Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype

por Fukuda, Takayo, Horii, Rie, Gomi, Naoya, Miyagi, Yumi, Takahashi, Shunji, Ito, Yoshinori, Akiyama, Futoshi, Ohno, Shinji, Iwase, Takuji
Publicado 2016

Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage

por Fukuda, Takayo, Wu, Wenwen, Okada, Maiko, Maeda, Ichiro, Kojima, Yasuyuki, Hayami, Ryosuke, Miyoshi, Yasuo, Tsugawa, Ko-ichiro, Ohta, Tomohiko
Publicado 2015

MO33-7 Preparedness for COVID-19 pandemic and impact on medical oncology for breast cancer

por Inagaki, Lina, Fukuda, Takayo, Uehiro, Natsue, Kataoka, Akemi, Morizono, Hidetomo, Kurata, Mami, Kawai, Saori, Masuda, Jun, Shibayama, Tomoko, Ozaki, Yukinori, Hosonaga, Mari, Fukada, Ippei, Kobayashi, Kokoro, Hara, Fumikata, Kobayashi, Takayuki, Ueno, Takayuki, Takano, Toshimi, Ito, Yoshinori, Takahashi, Shunji, Ohno, Shinji
Publicado 2021